Showing 3 of 3 recruiting trials for “Buerger disease”
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Enrolling by InvitationNCT07023965 ↗
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
👨⚕️ Hanafiah Harunarashid, MS, National University of Malaysia📍 1 site📅 Started Jan 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →